Genencor to Commercialize Decontamination Technology
By Biotechdaily staff writers
Posted on 02 Mar 2004
An exclusive license to manufacture and sell enzymes to decontaminate certain organophosphate-based nerve agents such as sarin has been granted to Genencor (Palo Alto, CA, USA) by the U.S. Army Edgewood Chemical Biological Center (ECBC, Aberdeen Proving Ground, MD, USA).Posted on 02 Mar 2004
Genencor plans to scale up and manufacture the enzymes that can be added to water and dispensed in foams, sprays, or detergents. The enzymes will be made available to military and civilian first responders, such as firefighters, police, and hazardous material response teams. The enzymes neutralize the chemical agents and have the benefit of being noncorrosive and environmentally friendly.
"This government-industry partnership demonstrates how the tools of biotechnology can be used to address important problems facing society,” said Jean-Jacques Bienaime, chairman and chief executive officer of Genencor. The company is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, consumer, and industrial markets.
Related Links:
Genencor
Edgewood Chemical Biological Center
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
.jpg)
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
